—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Ansell Ltd (ANN.AU) — the peer cohort

As of 2026-10-07 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Ansell Ltd ranks 3 of 11 in its cohort on the Closelooknet composite (64/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
ANN.AU Ansell Ltd 64 95 49 54 ok 0.9%
FPH.AU Fisher & Paykel Healthcare Corporation Ltd 61 83 72 29 ok 1%
ISRG Intuitive Surgical Inc 58 27 78 23 neutral 33%
YPSN.SW Ypsomed Holding AG 56 72 63 30 info 13.1%
AFX.DE Carl Zeiss Meditec AG 51 56 37 53 bull 34.1%
TECN.SW Tecan Group AG 49 93 28 53 ok 6.9%
EL.PA EssilorLuxottica S. A. 45 8 49 59 bear 53.6%
RHC.AU Ramsay Health Care Ltd 45 91 24 53 ok 2.6%
TLX.AU TELIX Pharmaceuticals Ltd 36 61 28 18 info 12.9%
BION.SW BB Biotech AG 74 63 96 81 info 12.3%
DXCM DexCom Inc 66 83 81 38 bear 9.9%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-07

Quick answers

Who are Ansell Ltd's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Fisher & Paykel Healthcare Corporation Ltd (FPH.AU), Intuitive Surgical Inc (ISRG), Ypsomed Holding AG (YPSN.SW), Carl Zeiss Meditec AG (AFX.DE), Tecan Group AG (TECN.SW), EssilorLuxottica S. A. (EL.PA), Ramsay Health Care Ltd (RHC.AU), TELIX Pharmaceuticals Ltd (TLX.AU) and others.

How does ANN.AU score against its peers?

Ansell Ltd's composite reads 64/100, ranking 3 of 11 in its cohort as of 2026-10-07; the cohort's highest composite is BB Biotech AG at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.